METASTATIC COLORECTAL CANCER (MCRC)
Clinical trials for METASTATIC COLORECTAL CANCER (MCRC) explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLORECTAL CANCER (MCRC) trials appear
Sign up with your email to follow new studies for METASTATIC COLORECTAL CANCER (MCRC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat colon cancer
Disease control Not yet recruitingThis study is testing a new oral drug, LPM6690176, to see if it is safe and effective when added to standard chemotherapy for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). The first part of the study will find the safest …
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE1, PHASE2 • Sponsor: Luye Pharma Group Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New combo attack on tough GI cancers
Disease control Not yet recruitingThis study is testing whether adding two new drugs (zanidatamab and tislelizumab) to standard chemotherapy or radiation works better for people with HER2-positive stomach or colorectal cancers. It will involve about 70 adults with specific types of advanced or spreading cancer. T…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: PHASE2 • Sponsor: Tao Zhang • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI-Powered test aims to match cancer patients with best drugs
Diagnosis Not yet recruitingThis study is testing a new diagnostic tool called µCAN for people with advanced colorectal cancer that has spread. The test analyzes a small sample of a patient's tumor in a lab, using machine learning to screen how it reacts to different drugs. The goal is to give doctors a per…
Matched conditions: METASTATIC COLORECTAL CANCER (MCRC)
Phase: NA • Sponsor: Oncosyne AS • Aim: Diagnosis
Last updated Mar 24, 2026 12:02 UTC